financetom
Business
financetom
/
Business
/
Alkermes Insider Sold Shares Worth $3,234,382, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alkermes Insider Sold Shares Worth $3,234,382, According to a Recent SEC Filing
Feb 3, 2025 12:32 AM

03:12 AM EST, 02/03/2025 (MT Newswires) -- Craig C. Hopkinson, Executive Vice President, Research & Development, Chief Medical Officer, on January 30, 2025, sold 100,918 ordinary shares in Alkermes ( ALKS ) for $3,234,382. Following the Form 4 filing with the SEC, Hopkinson has control over a total of 44,290 shares of the company, with 44,290 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1520262/000112760225002645/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sempra to Sell 45% Stake in Infrastructure Unit to KKR Affiliates for $10 Billion
Sempra to Sell 45% Stake in Infrastructure Unit to KKR Affiliates for $10 Billion
Sep 23, 2025
08:09 AM EDT, 09/23/2025 (MT Newswires) -- Sempra ( SRE ) said Tuesday it agreed to sell a 45% equity interest in Sempra Infrastructure Partners to affiliates of KKR (KKR) for $10 billion in cash. The $10 billion transaction implies a $22.2 billion equity value as well as a $31.7 billion enterprise value for Sempra Infrastructure Partners, the energy infrastructure...
Form 8.3 - Spectris PLC
Form 8.3 - Spectris PLC
Sep 23, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Mckesson raises annual profit forecast
Mckesson raises annual profit forecast
Sep 23, 2025
Sept 23 (Reuters) - U.S. drug distributor McKesson on Tuesday raised its annual profit forecast to range of $38.05 to $38.55 from its prior expectation of per-share profit being in the range of $37.10 to $37.90. (Reporting by Mrinalika Roy in Bengaluru) ...
Microbix Biosystems Launches New Genetic-Test EQA Program
Microbix Biosystems Launches New Genetic-Test EQA Program
Sep 23, 2025
08:07 AM EDT, 09/23/2025 (MT Newswires) -- Microbix Biosystems ( MBXBF ) Tuesday said a program to support rapid accurate identification of patients who carry gene-variants that may impede the effectiveness of an antiplatelet (anti-clotting) drug Clopidogrel is now live. This external quality assessment (EQA) program is to help ensure the proficiency of sites performing point-of-care tests. Over 20% of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved